Esposito ACC, Gige TC, Miot HA. Syndrome in question: antisynthetase syndrome (anti-PL-7).
An Bras Dermatol 2017;
91:683-685. [PMID:
27828653 PMCID:
PMC5087238 DOI:
10.1590/abd1806-4841.20164449]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2015] [Accepted: 04/22/2015] [Indexed: 11/22/2022] Open
Abstract
Antisynthetase syndrome is a rare autoimmune disease characterized by
interstitial lung disease and/or inflammatory myositis, with positive
antisynthetase antibodies (anti-Jo-1, anti-PL-7, anti-PL-12, ZO, OJ, anti-KE or
KS). Other symptoms described include: non-erosive arthritis, fever, Raynaud's
phenomenon, and "mechanic's hands." The first therapeutic option is
corticotherapy, followed by other immunosuppressants. The prognosis of the
disease is quite limited when compared to other inflammatory myopathies with
negative antisynthetase antibodies.
Collapse